Viveve non-invasive treatment for vaginal laxity by Dr. Lucy Abdala

Viveve is a non-invasive technology designed to address vaginal laxity, a common sexual concern. Similar to skin, vaginal tissue is made up of collagen fibers that weaken over time due to pregnancy, childbirth, weight changes, or natural aging.

Viveve uses a device that stimulates new collagen production at the vaginal entrance, enhancing friction and sexual pleasure for both the woman and her partner. This vaginal radiofrequency treatment also increases circulation to the clitoral area, supporting orgasm.

Additionally, Viveve can improve mild to moderate urinary incontinence, reducing involuntary urine leaks that affect quality of life and may lead to urinary or vaginal infections.

Viveve is a non-surgical, painless medical treatment lasting about 30 minutes, performed in-office without anesthesia or downtime. It strengthens collagen at the cellular level, tightening tissues at the vaginal opening gradually and safely, enhancing sexual sensations during intercourse.

If you have noticed changes in sexual sensation due to vaginal laxity affecting your sexual satisfaction, Viveve may help restore comfort and intimate confidence.

The procedure is performed in a gynecological position. The doctor gently inserts a thumb-sized device into the vaginal opening, rotating it progressively to cool the superficial tissue and slightly heat the deeper tissue, triggering the body’s natural collagen and elastin production.

This dual heating and cooling action activates natural tissue regeneration, ensuring patient safety and comfort.

No, the Viveve procedure is completely painless and comfortable for patients.

Yes, Viveve is safe. The radiofrequency energy used has been applied for over a decade on delicate facial, neck, and hand skin, with clinical trials confirming its safety. As with any medical procedure, the doctor will review individual safety considerations.

One treatment initiates vaginal collagen regeneration. Full effects appear gradually over 30 to 90 days. Clinical trials report 90% of women experienced significant vaginal tightness, lasting up to 12 months with an average improvement of 68%.

The treatment enhances elasticity and tension at the vaginal introitus, increasing friction sensation and better transmitting stimulation to the clitoris, supporting female orgasm.

• Only vaginal treatment supported by double-blind, randomized, controlled clinical studies.
• Non-surgical option with a single session.
• Monopolar radiofrequency technology with controlled cooling for patient comfort.
• Addresses vaginal laxity, a common cause of reduced sexual satisfaction for women and their partners.
• Positive and satisfying results for patients worldwide; Viveve focuses on how you feel, not just how you look.